Top 50 Medical VC Funds & Investors in Sweden (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Almi Invest
VC Fund
|
24 | Sweden, United States, Norway | Seed, Venture - Series Unknown | Software, Health Care, Information Technology | $230k–$2.6M |
|
Chalmers Ventures AB
VC Fund
|
13 | Sweden | Pre-Seed, Seed, Venture - Series Unknown | Software, Biotechnology, Information Technology | $5.8k–$3.5M |
|
Sciety
VC Fund
|
9 | Sweden, Ukraine | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $128k–$6.9M |
|
Hadean Ventures
VC Fund
|
6 | Sweden, Norway, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $2M–$79M |
|
Sweet Studio
VC Fund
|
5 | Sweden | Pre-Seed, Venture - Series Unknown, Seed | iOS, Apps, Audio | $106k–$3.8M |
|
Index Ventures
VC Fund
|
4 | United States, United Kingdom, France | Series A, Series B, Seed | Software, E-Commerce, Internet | $1.5M–$102M |
|
Bonit Capital
VC Fund
|
4 | Sweden, United States, Germany | Seed, Venture - Series Unknown | Health Care, Medical, Apps | $1.1M–$5.1M |
|
Partnerinvest Norr
VC Fund
|
4 | Sweden, United States | Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $359k–$6.1M |
|
Fåhraeus Startup and Growth
VC Fund
|
4 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Series A | Medical, Health Care, Biotechnology | $851k–$7.3M |
|
Add Health Media
VC Fund
|
4 | Sweden, India | Seed, Venture - Series Unknown | Health Care, Medical, Apps | $251k–$2.6M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $400k–$17M |
|
SEB Venture Capital
VC Fund
|
3 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Scale Capital
VC Fund
|
3 | Denmark, Norway, Sweden | Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $1M–$6.1M |
|
Flerie Invest
VC Fund
|
3 | Sweden, United States, United Kingdom | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Pharmaceutical | $2.5M–$75M |
|
Norrsken VC
VC Fund
|
3 | Sweden, United Kingdom, Germany | Seed, Series A, Venture - Series Unknown | Software, Food and Beverage, Artificial Intelligence | $893k–$156M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Industrifonden
VC Fund
|
3 | Sweden, United States, Denmark | Series A, Venture - Series Unknown | Biotechnology, Software, Information Technology | $2.8M–$21M |
|
Creandum
VC Fund
|
3 | Sweden, Germany, United States | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.8M–$80M |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Venture - Series Unknown, Seed | Biotechnology, Health Care, Pharmaceutical | $4.7M–$6.9M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
GU Ventures
VC Fund
|
2 | Sweden, United States | Seed, Series A, Venture - Series Unknown | Pharmaceutical, Medical, Recycling | $658k–$73M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
Otiva
VC Fund
|
2 | Sweden, France, United Kingdom | Seed, Series A, Venture - Series Unknown | E-Commerce, Food and Beverage, Fashion | $700k–$67M |
|
Inbox Capital
VC Fund
|
2 | Sweden, United States, United Arab Emirates | Venture - Series Unknown, Seed, Series A | Software, Apps, FinTech | $1.2M–$20M |
|
Gunnar Nilsson Cancer Foundation
VC Fund
|
2 | Sweden | Seed, Series A | Medical, Genetics, Biotechnology | |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
Heartcore Capital
VC Fund
|
2 | Denmark, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, FinTech | $1.2M–$58M |
|
Sting Capital
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Software, Apps, Medical | $216k–$776k |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A, Pre-Seed | Health Care, Medical, Fitness | $423k–$20M |
|
LU Ventures
VC Fund
|
2 | Sweden | Venture - Series Unknown, Pre-Seed | Medical, SaaS, Software | $336k–$1.6M |
|
Project A Ventures
VC Fund
|
2 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$75M |
|
GOBIA Enterprises
VC Fund
|
2 | Sweden | Seed, Series A, Venture - Series Unknown | Medical, Health Care, Eyewear | |
|
Uppsala universitet Invest AB
VC Fund
|
2 | Sweden | Seed | Medical, Health Diagnostics, CleanTech | $727k–$1.8M |
|
Metsa Spring
VC Fund
|
2 | Finland, Sweden | Seed, Venture - Series Unknown, Series A | GreenTech, Sustainability, Chemical | $395k–$8.3M |
|
Sweet Capital
VC Fund
|
2 | United States, United Kingdom, Sweden | Seed, Series A, Venture - Series Unknown | Apps, Software, Mobile | $443k–$45M |
|
3T Invest
VC Fund
|
2 | Sweden, India | Seed, Series A, Angel | Health Care, Medical, Software | $454k–$6.5M |
|
Accel
VC Fund
|
2 | United States, India, United Kingdom | Series A, Series B, Seed | Software, SaaS, Information Technology | $1.4M–$70M |
|
20 North Street
VC Fund
|
2 | Sweden | Venture - Series Unknown | SaaS, Medical, mHealth | $2.4M–$10M |
|
Jovitech Invest
VC Fund
|
2 | Sweden | Seed | Solar, Medical, Recycling | $395k–$1M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Bonnier Capital
VC Fund
|
1 | Sweden, Finland, Germany | Seed, Series A | Internet, Software, E-Commerce | $1M–$21M |
|
Zentynel Frontier Investments
VC Fund
|
1 | United States, Sweden | Series A, Seed, Angel | Health Care, Baby, Fitness | |
|
Webrock Ventures
VC Fund
|
1 | Brazil, Sweden | Series A, Seed | Health Care, Marketplace, Business Intelligence | |
|
Segulah Medical Acceleration
VC Fund
|
1 | Sweden, Germany, United States | Series A, Series D, Series B | Health Care, Medical Device, Biotechnology | |
|
Centripetal
VC Fund
|
1 | Sweden, India, Denmark | Seed, Secondary Market, Venture - Series Unknown | E-Commerce, Health Care, Financial Services | $1.5M–$3.8M |
|
Navigare Ventures
VC Fund
|
1 | Sweden, Denmark | Seed, Pre-Seed | Biotechnology, Health Care, Energy | |
|
Sunstone Life Science Ventures
VC Fund
|
1 | Denmark, Sweden, Switzerland | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$61M |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $16M–$180M |
|
Corinthian Properties
VC Fund
|
1 | Sweden | Seed | Medical, Manufacturing, Medical Device | |
|
Dendera Ventures
VC Fund
|
1 | Sweden | Seed, Venture - Series Unknown | News, Events, Medical | |
| Access all 232 VC funds in Sweden Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States, Norway
Investor stats
- Total investments: 478
- Round size: Seed $230k–$2.2M; Venture - Series Unknown $359k–$2.6M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $64M in 2024
Portfolio highlights
- Brighteco — Brighteco is an innovative and value-driven Born Circular startup that offers Light as a Service. All Brighteco hardware are build modular and circular from e.g reused computer screens.
- Boka konferens — Boka konferens provides an online booking platform that allows users to browse and book conference rooms and venue space for corporate offices. Their products serve consumers. For inquiries, their telephone number and email address are available on their website.
- Inhalation Sciences — The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a fullPK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 274
- Round size: Seed $274k–$2.3M; Pre-Seed $5.8k–$349k; Venture - Series Unknown $337k–$3.5M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Solinide Photonics — Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies.
- InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 46
- Round size: Seed $128k–$2.3M; Series A $457k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- Everdrone — Advanced drone operations for public safety and emergency response
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Sweden, Norway, Austria
Investor stats
- Total investments: 34
- Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $168M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
We co-found companies, dedicating our in-house team of designers, developers, and marketers to bring ideas to life. With every venture we co-found, our mission is to advance the consumer experience across industries with world-class technology, data-informed design, and lots of heart. Are you an entrepreneur who shares our mission?
Show more...Investment focus
- Industry: iOS, Apps, Audio
- Stage:Pre-Seed, Venture - Series Unknown, Seed
- Geography: Sweden
Investor stats
- Total investments: 7
- Round size: Pre-Seed $172k–$400k; Venture - Series Unknown $106k–$3.8M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Koo! — Koo! is an audio based social networking service that let users record and listen to 1-minute audio clips called Koos.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- Stride Leadership — Stride is the revolutionary leadership product built to help become a confident leader. For too long, we’ve been taught that leadership is an elite act that’s linked to your job title. Now you hold leadership development in your hand, regardless of your age, job title, or seniority.With Stride, you’ll learn what it truly means to lead, and how todo it. We’ll bust common myths and you’ll discover which style of leadership is the best fit for you. Designed by leadership and design experts, Stride will help you learn the mindset required, the basics of leadership, and techniques for dealing with inevitable challenges. Whether you’re new to leadership or you’re a seasoned professional you’ll love learning and forming new habits with Stride.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 1505
- Round size: Seed $1.5M–$15M; Series A $5M–$35M; Series B $12M–$102M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely actively investing — fresh fund, raised $400M in 2026
Portfolio highlights
- Anrok — Anrok automates sales tax compliance across your financial stack, so you can grow your SaaS business in any market.
- OpenX — OpenX has the largest independent ad exchange network for publishers and demand partners, while maintaining the highest quality marketplace standards. Learn more.
- StorSimple — Learn how to migrate a StorSimple 8100 or 8600 appliance to Azure File Sync.
Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 13
- Round size: Seed $1.8M–$4.2M; Venture - Series Unknown $1.1M–$5.1M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Vården.se — Vården.se is Sweden's largest private search service in healthcare and health .
- Bentley — Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 70
- Round size: Seed $442k–$2M; Venture - Series Unknown $359k–$6.1M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $32M in 2009
Portfolio highlights
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 14
- Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Add Health Media is a company that specializes in creating marketing materials for health companies.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, India
Investor stats
- Total investments: 19
- Round size: Seed $251k–$2.6M; Venture - Series Unknown $320k–$1.1M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Eatit — Eatit is a digital therapeutics platform for obesity treatment by dietitians.
- Dropmed — Dropmed is a Stockholm-based startup aiming to digitally transform medical device sales by providing groundbreaking tools for E-Commerce enablement and guided purchasing.
- Migränhjälpen — Migränhjälpen is providing digital health services.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 52
- Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- SNERPA Power — SNERPA Power develops intelligent energy services.
- Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 75
- Round size: Series A $1.2M–$12M; Series B $2.2M–$23M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — Apica is the agentic-ready telemetry pipeline that cuts observability costs up to 40%. Control your data, eliminate tool sprawl, and scale for AI.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Scale Capital is an early-stage technology investor, helping Nordic, B2B, and tech founder teams scale and win in the US market.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark, Norway, Sweden
Investor stats
- Total investments: 28
- Round size: Seed $1M–$4.8M; Venture - Series Unknown $1.4M–$6.1M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $60M in 2022
Portfolio highlights
- Sonair — Make your robot safe, affordable, and efficient with the Sonair 3D ultrasonic sensor.
- Bsure — Manage your user identities in Microsoft Entra, reduce license costs, and increase security with bsure. Be cost-effective. Be secure.
- 6 Robotics OÜ — We exist to strengthen defence, protect nations, and deter conflict in an era defined by unmanned warfare.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 27
- Round size: Series A $2.5M–$21M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Food and Beverage, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 108
- Round size: Seed $893k–$14M; Series A $4.4M–$56M; Venture - Series Unknown $1.1M–$156M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $346M in 2024
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
- Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 178
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Venture - Series Unknown
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 202
- Round size: Series A $3.3M–$21M; Venture - Series Unknown $2.8M–$21M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
- Fibbl — Enhance your e-commerce store with high-quality 3D product visualization for footwear. Scale 3D, AR, and virtual try-on experiences to boost engagement and conversions.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
We support early-stage founders in building global, category-defining companies. From Seed to IPO and beyond.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 316
- Round size: Seed $1.8M–$17M; Series A $5.5M–$31M; Series B $8M–$80M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $545M in 2024
Portfolio highlights
- Rillet — Rillet automates majority of month-end close and offers powerful GAAP and SaaS reporting. The software has built-in revenue recognition, invoicing, and AI-powered accounting.
- Passionfroot — A workspace where you can manage your creator business and organise your finances so that you can optimise your creator-work-life balance.
- OLIX — OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial intelligence workloads. The company develops Optical Tensor Processing Units that execute matrix and tensor operations for training and running inference on large-scale machine learning models. Its hardware aims to increase performance and reducepower consumption relative to conventional electronic accelerators by processing data in the optical domain. Flux Computing focuses on infrastructure for generative AI and advanced neural networks, targeting data centers and organizations that require intensive model computation. The product stack centers on custom optical chips integrated with supporting electronics, control software, and tools that link into existing AI frameworks. Sales and partnerships primarily address customers building large AI clusters, research environments, and emerging applications that benefit from high-throughput, low-energy computation.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Venture - Series Unknown $4.7M–$6.9M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more...Investment focus
- Industry: Pharmaceutical, Medical, Recycling
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 10
- Round size: Seed $658k–$3.4M; Series A $2.3M–$73M; Venture - Series Unknown $794k–$1.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Mimbly — Mimbly creates sustainable water solution with a focus on water usage and micro-plastics. Our product The mimbox, recycles up to 70% of the water from washing machines while capturing the micro plastics released.
- NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 140
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Equity investment company doing Series A to late growth, private and public. Agile and long-term with no fixed holding period.
Show more...Investment focus
- Industry: E-Commerce, Food and Beverage, Fashion
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, France, United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $700k–$3.2M; Series A $3.2M–$12M; Venture - Series Unknown $13M–$67M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AllPlants — AllPlants operates as UK's vegan meal delivery service. All their packaging is 100% recyclable, partly compostable, and mostly reusable. They’re creating delicious dinners to inspire more plant-based living, so people + planet thrive together. To start that journey, They’re delivering their hand-prepared meals to doorsteps UK-wide.
- BlaBlaCar — BlaBlaCar is the world’s leading long-distance carpooling community, connecting people looking to travel long distances with drivers going the same way. They travel together and share the costs of the journey. The platform is engineered to create a secure, trust-based community with declared identities and full member profiles. Members can evenspecify how chatty they are from “Bla” to “BlaBlaBla”, hence the name BlaBlaCar. BlaBlaCar is creating a global people-powered network with a trusted community of drivers and passengers.Backed by Accel Partners, Insight Ventures, Index Ventures, Lead Edge Capital, Baring Vostok and ISAI, it operates in 22 countries across Europe, Russia, Turkey, Mexico, Brazil and India. The site and free mobile apps provide a range of features to create a secure, trust-based community and easy connections between drivers and passengers.BlaBlaCar is based in Paris with offices across a dozen of countries.
- Pet Media Group — Woof Woof. Europe's Largest Pet Marketplaces PetMediaGroup is the leading operator of online marketplaces for pets and related goods and services. Through our trusted and local brands, we help thousands of animals every day to find a new loving home as well as assist their human caregivers
Inbox Capital is a privately held investment company based in Stockholm, mainly focusing on disruptive and fast growing tech companies.
Show more...Investment focus
- Industry: Software, Apps, FinTech
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Sweden, United States, United Arab Emirates
Investor stats
- Total investments: 43
- Round size: Seed $1.2M–$5.9M; Series A $2.1M–$12M; Venture - Series Unknown $2.1M–$20M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Billogram — Since its start in 2011, Billogram has revitalized the outdated invoicing process by offering companies with recurring payments an intelligent digital platform. Using smart technology, we help companies strengthen their customer relations while also automating payment processes in a way that lowers costs, increases revenue, and reduces churn. Theresult is a payment that pays off for everyone.
- Carla — Carla creates the most convenient, transparent, and simple online platform for purchasing or leasing an electric car.
- Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
Gunnar Nilsson Cancer Foundation
Show more...Investment focus
- Industry: Medical, Genetics, Biotechnology
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 395
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- PTC Therapeutics — Translating Science. Transforming Lives.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Germany
Investor stats
- Total investments: 212
- Round size: Seed $1.2M–$12M; Series A $3.3M–$27M; Series B $9.6M–$58M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2024
Portfolio highlights
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- PhaseTree — Materials design simulation company - PhaseTree ApS
- Everywear Games — Everywear Games is the world’s leading wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s gamesare consistently on top of global charts.
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more...Investment focus
- Industry: Software, Apps, Medical
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 16
- Round size: Seed $216k–$776k; Pre-Seed $412k–$611k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
- Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
- Minnemera — Minnemera develops digital neurocognitive tests.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A, Pre-Seed
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 20
- Round size: Seed $423k–$6.3M; Series A $3M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
LU Ventures, part of Lund University Innovation, co-founds spin-off companies with university researchers to commercialize research and drive global impact. It supports academics in building companies while allowing them to stay in academia, funding IP costs, recruiting CEOs/CTOs and board experts, and establishing legal/financialframeworks to attract external capit
Show more...Investment focus
- Industry: Medical, SaaS, Software
- Stage:Venture - Series Unknown, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $336k–$1.6M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Waveium — Waveium develops a cloud-based SaaS platform that provides instant wireless design simulations and validation for engineers and wireless developers. The platform enables users to test and optimize wireless systems in real time using scalable, automated simulations. It exposes functionality through an API so teams can integrate wireless performancetesting into network planning, product development workflows, and AI training pipelines. Waveium focuses on reducing the time and cost of traditional measurement-based wireless validation while supporting experimentation with new wireless features.
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Aventera Antibodies — Developing a First-in-Class Therapy for Invasive Group A Streptococcal Infections.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 222
- Round size: Seed $1.5M–$8.9M; Series A $3.3M–$27M; Series B $11M–$75M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $377M in 2025
Portfolio highlights
- Nexcade — Nexcade AI agents run freight quoting, tenders, rates, bookings, and reporting with your team, visible and controlled at every step.
- Project Q — European defence integration. Deployed with Bundeswehr, validated at NATO. Open-core, ITAR-free, no vendor lock-in. Connect sensors to C2 in seconds.
- STARK — EUROPEAN DEFENCE SOVEREIGNTY
GOBIA Enterprises is owned by Jan G Smith who has been active in the pharmaceutical industry.
Show more...Investment focus
- Industry: Medical, Health Care, Eyewear
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Njord Medtech — Njord develops Medtech products to help improve productivity at hospitals.
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Uppsala universitet Invest AB focuses on investment management, particularly in early-stage ventures. The company collaborates with researchers and students, providing financial support and strategic guidance for innovative projects. It aims for long-term investment horizons, typically ranging from 5 to 15 years. Uppsala universitet Invest AB alsopartners with other investors and co-financiers to support research-driven initiatives.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, CleanTech
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $727k–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Caplyzer — Caplyzer develops and patented a new solution for water electrolysis.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
- Readily Diagnostics — Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster and more effective therapy at the point of care.
We boldly invest in and support promising startups and potential innovations that explore new uses for sustainably-grown Nordic wood.
Show more...Investment focus
- Industry: GreenTech, Sustainability, Chemical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 12
- Round size: Seed $395k–$5.9M; Series A $4.4M–$8.3M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- FineCell — FineCell is a sustainable cellulose microfibers provider that enables manufacturers to make new products with reduced carbon footprints and differentiated properties.The company's cellulose microfibers possess physical and chemical properties that differ from competing products and provide differentiated benefits for the users. It has beensupported by Vinnova (Sweden’s innovation agency) and EIT InnoEnergy.The Linköping, Ostergotlands Lan-based company was established in 2015 by Jonatan Henschen, Jonas Engstrand, Monica Ek, and Kloce Dongfang Li.
- Fiberwood — Fiberwood is a new eco-friendly wood fiber insulation that can be used for a variety of purposes. Fiberwood has excellent insulating properties, is entirely bio-based, and thus contains no plastic or other fossil-based materials.
Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).
Show more...Investment focus
- Industry: Apps, Software, Mobile
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, United Kingdom, Sweden
Investor stats
- Total investments: 70
- Round size: Seed $1.8M–$5M; Series A $3M–$32M; Venture - Series Unknown $443k–$45M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Pachama — Harnessing AI to drive carbon capture and protect global forests
- The Expert — Book consultations with the world's top design experts
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
3T Invest started an interesting and fulfilling journey back in 2009. From the beginning they focused on the establishment of sustainable Venture Capital, supporting innovation and entrepreneurship. they are always committed to backing outstanding entrepreneurs with the necessary resources.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Angel
- Geography: Sweden, India
Investor stats
- Total investments: 11
- Round size: Seed $454k–$964k; Series A $3.2M–$6.5M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- Predicare — Predicare develops a decision support system for healthcare called RETTS. RETTS' fast emergency triage and treatment system works by measuring and assessing vital parameters at the first examination, as well as by gathering a structured and standardized medical history regarding the reason for the visit and the patient’s current symptoms.Predicare was founded in 2011 and is headquartered in Gothenburg, Sweden.
- Warp News — News that is optimistic and based on facts. The world is better now than ever before, but mainstream media has a negative bias. We balance that.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 2354
- Round size: Seed $1.4M–$10M; Series A $4.4M–$40M; Series B $9.5M–$70M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely actively investing — fresh fund, raised $750M in 2026
Portfolio highlights
- Yodlee — Yodlee is a provider of financial applications that aims to make online banking more profitable. Yodlee's personal financial management, payments, and customer acquisition solutions unify all personal financial account information to deliver centralized way for users to manage their financial tasks.
- MobStac — Developer of a cloud-based mobile marketing platform designed to connect the digital and physical worlds through the use of innovative technology. The company's platform is based on the principals of proximity marketing and engage customers in a personalized, context-aware way that leverages indoor location and proximity, enabling businessesand brands to leverage BLE beacon technology to deliver context-rich experiences to their end users.
- Diligent — Diligent, a modern governance company, is the only comprehensive governance software provider featuring tools to improve and simplify modern day governance.
20 North Street is the name HDR Partners uses when adding investors and industrial experience to small growth companies.
Show more...Investment focus
- Industry: SaaS, Medical, mHealth
- Stage:Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $2.4M–$10M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Innspire — Innspire, founded on 2012 by Martin Chevalley, developed a software solution enabling guests to connect their own devices to the hotels' technology system.
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
Jovitech Invest help entrepreneur-led companies to grow profitably through active, long-term ownership
Show more...Investment focus
- Industry: Solar, Medical, Recycling
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $395k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- Mat4Green Tech — Mat4Green Tech develops a technology that recycles Indium from industrial waste in an efficient and climate-neutral way.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
- Last fund: Likely still investing — raised $34M in 2024
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
- Perfat Technologies — Perfect fats for better foods.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies of various sizes.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Series A
- Geography: Sweden, Finland, Germany
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.9M; Series A $3.4M–$21M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Acast — Want to start a podcast? Acast can help. We're the world's leading independent podcast company, helping creators and advertisers reach listeners globally.
- AAC Clyde Space —
- Mediaflow Europe — Mediaflow Europe is a SaaS company that provides its platform for image, video, design, templates, and document sharing and management.
Zentynel Frontier is a investment firm.
Show more...Investment focus
- Industry: Health Care, Baby, Fitness
- Stage:Series A, Seed, Angel
- Geography: United States, Sweden
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Asclepii — Multi-dimensional Wound Healing | Cell therapy is the future of human health. | Regenerative medicine for modern wound care.
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
- MultiplAI Health — Universal genomic screening for virtually any complex diseases, including cardiovascular disorders and cancer.
We are a team of entrepreneurs and investment professionals, building digital platforms to empower Brazilians. Since 2016, we have partnered with leading Swedish technology companies to build, invest and support successful companies in Brazil.
Show more...Investment focus
- Industry: Health Care, Marketplace, Business Intelligence
- Stage:Series A, Seed
- Geography: Brazil, Sweden
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- ViBe Saúde — Brazil's #1 Digital Health App. Telemedicine + Digital Therapeutics + Health & Wellness.
- Doktor.se — Doktor.se is a modern and personal care company working with digital healthcare. They are in an expansive phase, they have several offices in Sweden and grow sharply.With experienced specialist nurses, doctors and psychologists, they help their members to get quick and effective care. Their goal is to deliver a whole new level of service withinSwedish care.They help with counseling, book doctor hours, distance care, recipes, referrals, and much more. They always follow every case through their app. They also provide exclusive care and health offers as well as collecting interesting articles and news that will suit the clients.Doktor.se is an approved healthcare provider its counseling and booking are carried out by certified healthcare professionals and specialists in their area. Doktor.se also owns physical primary care and has extensive experience in Swedish healthcare.
- FinanZero — FinanZero is the leading online marketplace for consumer loans in Brazil. The business is an independent broker for loans, negotiating the customer’s loan application with several banks and credit institutions, to find the loan with the best interest rate and terms for the consumer. FinanZero handles the lending process from start to finish.FinanZero has more than 50 lending partners connected to its platform.The company was founded in 2015 and is based in São Paulo, Brazil.
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series A, Series D, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Signifier Medical Technologies — Driving Innovation in the Sleep Market Signifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.
Centripetal Capital is an investment firm.
Show more...Investment focus
- Industry: E-Commerce, Health Care, Financial Services
- Stage:Seed, Secondary Market, Venture - Series Unknown
- Geography: Sweden, India, Denmark
Investor stats
- Total investments: 28
- Round size: Seed $1.5M–$3.8M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Quartr — Download the Quartr app to access investor calls/presentations, earnings reports, slide decks and transcripts without friction (and for free!)
- Nextory — Nextory is an online collection of e-books in pdf and audio formats
- Doktor.se — Doktor.se is a modern and personal care company working with digital healthcare. They are in an expansive phase, they have several offices in Sweden and grow sharply.With experienced specialist nurses, doctors and psychologists, they help their members to get quick and effective care. Their goal is to deliver a whole new level of service withinSwedish care.They help with counseling, book doctor hours, distance care, recipes, referrals, and much more. They always follow every case through their app. They also provide exclusive care and health offers as well as collecting interesting articles and news that will suit the clients.Doktor.se is an approved healthcare provider its counseling and booking are carried out by certified healthcare professionals and specialists in their area. Doktor.se also owns physical primary care and has extensive experience in Swedish healthcare.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 63
- Round size: Series A $5.5M–$61M; Series B $9.6M–$58M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $92M in 2019
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 219
- Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$111M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fresh fund, raised $606M in 2026
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Corinthian Properties is an investment Firm.
Show more...Investment focus
- Industry: Medical, Manufacturing, Medical Device
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amferia — Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria. Our dominant focus iswithin the wound care sector, producing preventive care wound patches for the pressing need to avoid antibiotic resistant skin infections. Amferia’s proprietary anti-infective technology is a result of several years of research from Chalmers University of Technology and is patent protected.
Just another WordPress site
Show more...Investment focus
- Industry: News, Events, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ifrågasätt — Ifrågasätt is a startup based in Malmö, Sweden, that will become the media world’s #1 supplier of traffic, loyalty and user engagement. Working together with customers, Ifrågasätt offers cost-efficient products to help news sites regain and keep readers and increase their engagement, while building reader loyalty.Ifrågasätt’s first product,launched in Sweden August 2017, is a commenting service that is easily implemented on the customers’ — the newspapers — own sites. The commenting service consists of not only a technical commenting solution, but also manual AI/ML-supported 24/7 moderation, traffic-increasing activities, as well as user verification and user management.In less then a year, Ifrågasätt has gained a lot of publicity and traction and has already signed multiple customers, including Sweden’s largest daily newspaper (Dagens Nyheter), Sweden’s largest regional newspaper (Göteborgs-Posten) and the Nordics’ largest business journal (Dagens industri).
- Joint Academy — Create clinically proven home exercise & treatment programs with AI
Medical VC funding in Sweden at a glance
Stats across 302 deals from 232 investors.
Access all 232 VC funds in Sweden Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 232 VC funds investing in Sweden Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!